EasySep™小鼠TIL（CD45）正选试剂盒
The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib.
The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib.
很抱歉, 生成此内容时发生错误。
沪公网安备31010102008431号